Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
11 studies found for:    Alzheimer's Genentech
Show Display Options
Rank Status Study
1 Completed A Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anti-Abeta (MABT5102A) in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: anti-Abeta;   Drug: placebo
2 Completed A Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY)
Condition: Alzheimer's Disease
Interventions: Drug: MABT5102A;   Drug: placebo
3 Completed A Study to Evaluate the Impact of MABT5102A on Brain Amyloid Load and Related Biomarkers in Patients With Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: MABT5102A;   Drug: placebo
4 Active, not recruiting A Study of Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers to Evaluate Efficacy and Safety in the Treatment of Autosomal-Dominant Alzheimer Disease (AD), Including a Placebo-Treated Noncarrier Cohort
Condition: Alzheimer's Disease
Interventions: Drug: Crenezumab;   Drug: Placebo
5 Completed A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With Crenezumab
Condition: Alzheimer's Disease
Intervention: Drug: Crenezumab
6 Recruiting Longitudinal Evaluation of [18F]MNI-798 as a PET Radioligand for Imaging Tau in the Brain of Patients With Alzheimer's Disease Compared to Healthy Volunteers
Condition: Alzheimer's Disease
Intervention: Drug: [18F]MNI-798
7 Active, not recruiting A Study of RO7105705 in Healthy Participants and Participants With Mild-to-Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Placebo;   Drug: RO7105705
8 Active, not recruiting A Study of Crenezumab in Participants With Mild to Moderate Alzheimer Disease
Condition: Alzheimer Disease
Interventions: Drug: Crenezumab dose level 1;   Drug: Crenezumab dose level 2;   Drug: Crenezumb dose level 3;   Drug: Placebo
9 Recruiting A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
Interventions: Drug: Crenezumab;   Drug: Placebo
10 Recruiting CREAD Study: A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)
Condition: Alzheimer's Disease
Interventions: Drug: Crenezumab;   Drug: Placebo
11 Not yet recruiting A Study to Evaluate the Efficacy of RO7046015 in Participants With Early Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: RO7046015;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.